Evidence map›Paper›PMID 10611362›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1999

Lethal paralysis of Caenorhabditis elegans by Pseudomonas aeruginosa.

C Darby, C L Cosma, J H Thomas, C Manoil

Open access · greenAbstract readComparative Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 138 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
138citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

138 citing papers in PubMed, 1 synthesis or guideline pooled it, 319 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Pantoea piersonii IIIF1SW-P2Scientific reports · 2025
    Article
  8. Review
  9. Review
  10. An insight on the powerful of bacterial quorum sensing inhibition.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Microorganisms · 2023
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

78 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

C DarbyDepartment of Genetics, University of Washington, Seattle, WA 98195, USA.
C L Cosma
J H Thomas
C Manoil
University of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Identification of host factors that interact with pathogens is crucial to an understanding of infectious disease, but direct screening for host mutations to aid in this task is not feasible in mammals. The nematode Caenorhabditis elegans is a genetically tractable alternative for investigating the pathogenic bacterium Pseudomonas aeruginosa. A P. aeruginosa toxin, produced at high cell density under control of the quorum-sensing regulators LasR and RhlR, rapidly and lethally paralyzes C. elegans. Loss-of-function mutations in C. elegans egl-9, a gene required for normal egg laying, confer strong resistance to the paralysis. Thus, activation of EGL-9 or of a pathway that includes it may lead to the paralysis. The molecular identity of egl-9 was determined by transformation rescue and DNA sequencing. A mammalian homologue of EGL-9 is expressed in tissues in which exposure to P. aeruginosa could have clinical effects.

Indexed as

Caenorhabditis elegans ProteinsAmino Acid SequenceAnimalsBacterial ProteinsCaenorhabditis elegansCell CommunicationDiffusionDNA-Binding ProteinsDNA, ComplementaryGenes, HelminthHelminth ProteinsMolecular Sequence DataMutationParalysisPseudomonas aeruginosaRecombinant Fusion ProteinsBacterial ProteinsCaenorhabditis elegans ProteinsDNA-Binding ProteinsDNA, ComplementaryEgl-9 protein, C elegansHelminth ProteinsLasR protein, Pseudomonas aeruginosaRecombinant Fusion ProteinsRhlR protein, Pseudomonas aeruginosaTrans-Activators

Identifiers

PMID10611362
PMCPMC24797
OpenAlexW2099977976

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.